← FDA DRUG APPROVALS

FDA ANDA · ANDA084696

PROCAINAMIDE HYDROCHLORIDE

Sponsor: LANNETT

APPLICATION
ANDA084696
TYPE
ANDA
ORIGINAL APPROVAL
1977-05-11
LATEST ACTION
1982-05-18
ROUTE
ORAL
DOSAGE FORM
CAPSULE
MARKETING STATUS
Discontinued

Products

PROCAINAMIDE HYDROCHLORIDEDiscontinued
PROCAINAMIDE HYDROCHLORIDE 500MG · CAPSULE · ORAL

Approval history

1982-05-18Manufacturing (CMC) · Supplement 12AP
1982-05-18Manufacturing (CMC) · Supplement 13AP
1977-05-11OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industry →GMP discipline →FDA drug shortages →FDA enforcement & recalls →

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →